OverTheHills
Senior Member
- Messages
- 465
- Location
- New Zealand
I am hoping, providing the UK & Norwegian studies turn out as expected, to try Rituximab in 1-3 years time.
I am in my mid 50s and have had ME/CFS for 10-12 years depending on where you count the start point. My appetite for risk is increasing as I age and therefore don't have as many more good quality years to hope for. So I am thinking to go for Ritux not wait for better treatments to be identified further down the line.
I'd like to suggest this thread to discuss/speculate on the realities/issues of making that happen. Also to think about anything we patients need to organise, prepare or lobby for.
For example: where? will any NZ rheumies be prepared to do this? I can enquire of Dr Vallings who runs the national ME society here. Otherwise it will be UK or US depending on cost. UK might be preferable as the experience of the first trial will already be there.
Paying: I expect public health services/insurance companies will regard the treatment as experimental for some years so if I can't get in on a study I will need to fund it privately. I am prepared to mortgage house/cash in pension/take a loan.
Paying 2: Is there a way to get an extra research bang for our buck if patients club together? ie leveraging some research extra from early adopters rather than our individual experiences being mere anecdote? Obviously there would be all sorts of selection bias/control issues but is there anything this sort of data could help explore - such as comparing different dosing schedules or adjunct treatments (non scientist
- you can tell right?).
Any answers/other questions?
OTH
I am in my mid 50s and have had ME/CFS for 10-12 years depending on where you count the start point. My appetite for risk is increasing as I age and therefore don't have as many more good quality years to hope for. So I am thinking to go for Ritux not wait for better treatments to be identified further down the line.
I'd like to suggest this thread to discuss/speculate on the realities/issues of making that happen. Also to think about anything we patients need to organise, prepare or lobby for.
For example: where? will any NZ rheumies be prepared to do this? I can enquire of Dr Vallings who runs the national ME society here. Otherwise it will be UK or US depending on cost. UK might be preferable as the experience of the first trial will already be there.
Paying: I expect public health services/insurance companies will regard the treatment as experimental for some years so if I can't get in on a study I will need to fund it privately. I am prepared to mortgage house/cash in pension/take a loan.
Paying 2: Is there a way to get an extra research bang for our buck if patients club together? ie leveraging some research extra from early adopters rather than our individual experiences being mere anecdote? Obviously there would be all sorts of selection bias/control issues but is there anything this sort of data could help explore - such as comparing different dosing schedules or adjunct treatments (non scientist
Any answers/other questions?
OTH